Product image of Mildronate (Meldonium Dihydrate) supplied by GNH India

Mildronate

Active Ingredient:
Meldonium Dihydrate
Origin:
EU

Mildronate (Meldonium Dihydrate)

Meldonium, the active ingredient in Mildronate, is a cardioprotective agent presented as an oral tablet. It is used to improve myocardial energy metabolism in patients with ischemic heart disease, angina pectoris, heart failure and cerebral ischemia, helping to increase tolerance to reduced oxygen supply.

GNH India supplies Mildronate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing consistent quality and regulatory compliance for global healthcare providers, including both public and private sector institutions, with established logistics for timely delivery.

Manufacturer / TM Owner

Grindeks

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Mildronate (meldonium) is employed in the management of cardiovascular and cerebrovascular conditions characterized by reduced oxygen supply.
  • Ischemic heart disease: improves myocardial tolerance to ischemia and reduces anginal episodes.
  • Angina pectoris: decreases frequency and severity of chest pain during exertion.
  • Heart failure: supports cardiac output by optimizing myocardial energy use.
  • Cerebral ischemia: may enhance neuronal resistance to hypoxic injury.

How It Works

  • Meldonium inhibits γ‑butyrobetaine hydroxylase, the key enzyme in endogenous carnitine synthesis. By lowering intracellular carnitine levels, the drug shifts myocardial energy metabolism from fatty‑acid oxidation toward glucose oxidation, which requires less oxygen per ATP generated. This metabolic reprogramming enhances cellular tolerance to ischemia and hypoxia, supporting cardiac and cerebral tissue during reduced blood flow.

Side Effects

Mildronate is generally well tolerated, but adverse reactions have been reported.

Common Side Effects

  • Headache: mild to moderate intensity, often transient.
  • Nausea: occasional gastrointestinal discomfort.
  • Dizziness: sensation of light‑headedness, especially on standing.
  • Insomnia: difficulty initiating or maintaining sleep.
  • Fatigue: feeling of reduced energy.
  • Gastrointestinal upset: mild abdominal discomfort.

Serious or Rare Side Effects

  • Hypotension: marked drop in blood pressure requiring monitoring.
  • Cardiac arrhythmia: irregular heart rhythm, potentially symptomatic.
  • Severe allergic reaction: rash, itching, swelling, or anaphylaxis.
  • Elevated liver enzymes: indication of hepatic stress.
  • Skin rash: extensive or blistering eruptions.
  • Myocardial injury: rare cases of worsening cardiac function.

Precautions & Warnings

  • Before initiating Mildronate, clinicians should consider several safety measures.
  • Assess cardiac function: perform baseline evaluation of heart status.
  • Monitor blood pressure: check regularly for hypotensive episodes.
  • Renal impairment: adjust use in patients with reduced kidney function.
  • Hypersensitivity: avoid in individuals with known allergy to meldonium.
  • Pregnancy and lactation: safety not established; weigh benefits against potential risks.
  • Store at ambient temperature (below 25 °C): keep in the original pack, protect from moisture.

Avoid Interactions

Mildronate may interact with other cardiovascular and metabolic agents.

Major Interactions (Avoid)

  • Concomitant use with other metabolic modulators (e.g., trimetazidine) may increase risk of hypotension.
  • Strong CYP450 inhibitors: although meldonium is not a major CYP substrate, co‑administration could alter drug levels.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: monitor heart rate and blood pressure.
  • Antihypertensives: watch for additive blood‑pressure‑lowering effects.
  • Diuretics: observe electrolyte balance and renal function.

Frequently Asked Questions

Mildronate (meldonium) is prescribed for ischemic heart disease, angina pectoris, heart failure and cerebral ischemia. It helps improve the heart’s ability to tolerate reduced oxygen supply by shifting energy metabolism toward glucose utilization.

Meldonium blocks the enzyme γ‑butyrobetaine hydroxylase, reducing the synthesis of carnitine. Lower carnitine levels shift myocardial energy production from fatty‑acid oxidation to glucose oxidation, a pathway that generates more ATP per unit of oxygen, thereby enhancing tolerance to ischemia.

The dosage of Mildronate is determined by the prescribing physician based on the patient’s clinical condition, severity of disease, and response to therapy. Patients should follow the specific dosing instructions provided by their healthcare professional.

Safety data for meldonium in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies the possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To request Mildronate, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mildronate differs from traditional anti‑ischemic agents such as nitrates or beta‑blockers by targeting cellular metabolism rather than vascular tone. It reduces reliance on fatty‑acid oxidation, whereas many alternatives primarily affect heart rate, contractility, or coronary vasodilation.

Mildronate tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original packaging, protect from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Mildronate is taken orally as a tablet. Patients should swallow the tablet whole with water, preferably at the same times each day, unless otherwise instructed by their healthcare provider.

Serious adverse events, though rare, can include significant hypotension, cardiac arrhythmias, severe allergic reactions, and hepatic enzyme elevations. Patients should seek immediate medical attention if they experience symptoms such as fainting, rapid heartbeat, rash, or jaundice.

Mildronate is contraindicated in individuals with known hypersensitivity to meldonium or any of its excipients. Caution is also advised for patients with severe renal impairment, uncontrolled hypotension, or those who are pregnant or breastfeeding without a clear medical justification.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Meldonium Dihydrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT